Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (20503) 20503
Newsletter (789) 789
Magazine Article (225) 225
Book Chapter (45) 45
Conference Proceeding (27) 27
Dissertation (22) 22
Book / eBook (20) 20
Newspaper Article (13) 13
Reference (11) 11
Publication (8) 8
Web Resource (6) 6
Streaming Video (4) 4
Book Review (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (17587) 17587
science & technology (10899) 10899
life sciences & biomedicine (10785) 10785
bronchodilator agents - therapeutic use (9757) 9757
male (9533) 9533
female (8602) 8602
bronchodilator agents - administration & dosage (7594) 7594
asthma - drug therapy (6874) 6874
respiratory system (5840) 5840
adult (5456) 5456
middle aged (5313) 5313
biological and medical sciences (5031) 5031
administration, inhalation (4908) 4908
medical sciences (4899) 4899
asthma (3980) 3980
aged (3740) 3740
abridged index medicus (3267) 3267
pulmonary disease, chronic obstructive - drug therapy (3133) 3133
bronchodilator agents - pharmacology (3116) 3116
child (3097) 3097
bronchodilator agents (3037) 3037
pharmacology. drug treatments (2804) 2804
adolescent (2784) 2784
treatment outcome (2616) 2616
general & internal medicine (2585) 2585
animals (2532) 2532
asthma - physiopathology (2321) 2321
bronchodilator agents - adverse effects (2295) 2295
double-blind method (2238) 2238
pharmacology & pharmacy (2193) 2193
albuterol - administration & dosage (2032) 2032
nebulizers and vaporizers (1985) 1985
drug therapy, combination (1818) 1818
albuterol - therapeutic use (1769) 1769
aerosols (1700) 1700
child, preschool (1679) 1679
drug therapy (1640) 1640
lung diseases, obstructive (1591) 1591
pneumology (1589) 1589
chronic obstructive pulmonary disease (1569) 1569
respiratory function tests (1537) 1537
forced expiratory volume (1512) 1512
time factors (1504) 1504
adrenal cortex hormones - therapeutic use (1485) 1485
pulmonary disease, chronic obstructive - physiopathology (1483) 1483
medicine, general & internal (1396) 1396
dose-response relationship, drug (1368) 1368
chronic obstructive pulmonary disease, asthma (1313) 1313
spirometry (1305) 1305
care and treatment (1276) 1276
research (1259) 1259
severity of illness index (1258) 1258
adrenergic beta-agonists - therapeutic use (1254) 1254
allergy (1254) 1254
forced expiratory volume - drug effects (1217) 1217
infant (1211) 1211
pediatrics (1208) 1208
albuterol - analogs & derivatives (1157) 1157
asthma - diagnosis (1137) 1137
critical care medicine (1135) 1135
copd (1132) 1132
salmeterol xinafoate (1024) 1024
pulmonary disease, chronic obstructive - diagnosis (983) 983
cross-over studies (952) 952
risk factors (942) 942
drug combinations (938) 938
bronchodilators (931) 931
lung - drug effects (923) 923
acute disease (922) 922
guinea pigs (912) 912
analysis (909) 909
formoterol fumarate (901) 901
fluticasone (895) 895
respiratory tract diseases (883) 883
adrenal cortex hormones - administration & dosage (872) 872
adrenergic beta-agonists - administration & dosage (861) 861
lung - physiopathology (859) 859
lung diseases, obstructive - drug therapy (838) 838
bronchodilator agents - pharmacokinetics (792) 792
health aspects (792) 792
prospective studies (791) 791
corticosteroids (789) 789
quality of life (785) 785
immunology (780) 780
clinical trials as topic (773) 773
dosage and administration (768) 768
drug administration schedule (757) 757
anti-inflammatory agents - therapeutic use (752) 752
budesonide - administration & dosage (752) 752
drugs (737) 737
theophylline - therapeutic use (733) 733
aged, 80 and over (730) 730
anti-asthmatic agents - therapeutic use (724) 724
chronic disease (712) 712
albuterol (692) 692
bronchi - drug effects (689) 689
budesonide (687) 687
respiratory therapy (678) 678
tiotropium bromide (675) 675
randomized controlled trials as topic (673) 673
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (18917) 18917
German (824) 824
French (573) 573
Russian (345) 345
Spanish (344) 344
Japanese (340) 340
Italian (178) 178
Polish (158) 158
Portuguese (125) 125
Chinese (110) 110
Dutch (71) 71
Danish (68) 68
Romanian (66) 66
Swedish (50) 50
Norwegian (38) 38
Czech (36) 36
Finnish (18) 18
Bulgarian (17) 17
Hungarian (17) 17
Croatian (16) 16
Hebrew (16) 16
Turkish (15) 15
Slovak (8) 8
Korean (5) 5
Lithuanian (4) 4
Serbian (4) 4
Ukrainian (3) 3
Afrikaans (2) 2
Icelandic (2) 2
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Beta₂-agonists in asthma treatment
by Pauwels, Romain and O'Byrne, Paul M
1997, Lung biology in health and disease, ISBN 9780824794965, Volume 106., xvi, 443
Adrenergic beta agonists | Chemotherapy | Therapeutic use | Asthma
Book
Details down arrow
2. Principles of pharmacology for respiratory care
by Bills, Georgine W and Soderberg, Robert C
1998, 2nd ed., ISBN 9780827382992, xvi, 384
Respiratory therapists | drug therapy | Respiratory Tract Diseases | Respiratory agents | Pharmacology | Bronchodilator Agents | Respiratory Therapy
Book
Details down arrow
3. Full Text Can Guideline-defined Asthma Control Be Achieved?: The Gaining Optimal Asthma ControL Study
by Bateman, Eric D and Boushey, Homer A and Bousquet, Jean and Busse, William W and Clark, Tim J. H and Pauwels, Romain A and Pedersen, Soren E and GOAL Investigators Group and GOAL Investigators Grp and GOAL Investigators Group
American journal of respiratory and critical care medicine, ISSN 1073-449X, 10/2004, Volume 170, Issue 8, pp. 836 - 844
Antiasthmatic agents | Salmeterol | Fluticasone propionate | Guidelines | Quality of life | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Emergency and intensive cardiocirculatory care. Cardiogenic shock. Coronary intensive care | Biological and medical sciences | Intensive care medicine | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Anti-Asthmatic Agents - adverse effects | Bronchodilator Agents - therapeutic use | Prospective Studies | Asthma - prevention & control | Bronchodilator Agents - administration & dosage | Forced Expiratory Volume - drug effects | Anti-Asthmatic Agents - therapeutic use | Humans | Male | Fluticasone | Adrenal Cortex Hormones - therapeutic use | Dose-Response Relationship, Drug | Time Factors | Albuterol - administration & dosage | Adult | Female | Surveys and Questionnaires | Bronchodilator Agents - adverse effects | Drug Therapy, Combination | Salmeterol Xinafoate | Double-Blind Method | Albuterol - analogs & derivatives | Treatment Outcome | Asthma - drug therapy | Androstadienes - administration & dosage | Quality of Life | Albuterol - therapeutic use | Androstadienes - therapeutic use | Anti-Asthmatic Agents - administration & dosage | Androstadienes - adverse effects | Albuterol - adverse effects | Adrenal Cortex Hormones - administration & dosage | Practice Guidelines as Topic | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Antitussive, antispasmodic, bronchodilating and cardiac inotropic effects of the essential oil from Blepharocalyx salicifolius leaves
by Hernández, Jehison Jiménez and Ragone, María Inés and Bonazzola, Patricia and Bandoni, Arnaldo L and Consolini, Alicia E
Journal of ethnopharmacology, ISSN 0378-8741, 01/2018, Volume 210, pp. 107 - 117
Blepharocalyx salicifolius | Antispasmodic | Essential oil | Antitussive | Bronchodilator | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Chemistry, Medicinal | Integrative & Complementary Medicine | Plant Sciences | Science & Technology | South America | Bronchodilator Agents - isolation & purification | Bronchodilator Agents - administration & dosage | Calcium - metabolism | Cough - drug therapy | Plant Extracts - pharmacology | Plant Leaves | Medicine, Traditional - methods | Male | Oils, Volatile - pharmacology | Parasympatholytics - isolation & purification | Antitussive Agents - pharmacology | Myrtaceae - chemistry | Plant Extracts - administration & dosage | Inhibitory Concentration 50 | Female | Oils, Volatile - administration & dosage | Disease Models, Animal | Parasympatholytics - administration & dosage | Rats | Bronchodilator Agents - pharmacology | Cardiotonic Agents - pharmacology | Oils, Volatile - isolation & purification | Parasympatholytics - pharmacology | Rats, Sprague-Dawley | Antitussive Agents - isolation & purification | Animals | Antitussive Agents - administration & dosage | Cardiotonic Agents - administration & dosage | Cardiotonic Agents - isolation & purification | Mice | Respiratory agents | Analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease
by Kew, Kayleigh M and Seniukovich, Alieksei and Kew, Kayleigh M
Cochrane library, ISSN 1469-493X, 2014, Volume 2014, Issue 12, pp. CD010115 - CD010115
Budesonide | Pneumonia | Lungs & airways | Pulmonary Disease, Chronic Obstructive | Respiratory infections: pneumonia | Androstadienes | Administration, Inhalation | Bronchodilator Agents | Fluticasone | Randomized Controlled Trials as Topic | Steroids, inhaled | Adrenergic beta‐2 Receptor Agonists | Child health | Respiratory infections | Anti‐Inflammatory Agents | Chronic obstructive pulmonary disease, stable ‐ pharmacotherapy | Drug Therapy, Combination | Medicine General & Introductory Medical Sciences | Adverse effects of treatments | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Male | Drug Therapy, Combination - methods | Androstadienes - administration & dosage | Anti-Inflammatory Agents - adverse effects | Adrenergic beta-2 Receptor Agonists - adverse effects | Pneumonia - chemically induced | Budesonide - adverse effects | Adrenergic beta-2 Receptor Agonists - administration & dosage | Anti-Inflammatory Agents - administration & dosage | Female | Budesonide - administration & dosage | Bronchodilator Agents - adverse effects | Androstadienes - adverse effects | Pulmonary Disease, Chronic Obstructive - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus
by Heijerman, Harry and Westerman, Elsbeth and Conway, Steven and Touw, Daan and Gerd Döring for the consensus working group and Consensus Working Grp and consensus working group
Journal of cystic fibrosis, ISSN 1569-1993, 2009, Volume 8, Issue 5, pp. 295 - 315
Pulmonary/Respiratory | Cystic fibrosis | Inhalation devices | Inhaled medication | Anti-Bacterial Agents | Cystic Fibrosis | Expectorants | Anti-Inflammatory Agents | Humans | Administration, Inhalation | Bronchodilator Agents | Lung Diseases | Respiratory System Agents | Drug Combinations | Nebulizers and Vaporizers | Life Sciences & Biomedicine | Respiratory System | Science & Technology | Bronchodilator Agents - administration & dosage | Cystic Fibrosis - complications | Lung Diseases - drug therapy | Lung Diseases - etiology | Expectorants - administration & dosage | Respiratory System Agents - administration & dosage | Anti-Inflammatory Agents - administration & dosage | Anti-Bacterial Agents - administration & dosage | Cystic Fibrosis - drug therapy | Development and progression | Respiratory agents | Care and treatment | Powders | Inhalers | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Combined inhaled beta‐agonist and anticholinergic agents for emergency management in adults with asthma
by Kirkland, Scott W and Vandenberghe, Christine and Voaklander, Britt and Nikel, Taylor and Campbell, Sandra and Rowe, Brian H and Kirkland, Scott W
Cochrane library, ISSN 1469-493X, 01/2017, Volume 2017, Issue 1, pp. CD001284 - CD001284
Ipratropium | Lungs & airways | Anti‐Asthmatic Agents | Asthma, acute ‐ pharmacotherapy | Asthma | Randomized Controlled Trials as Topic | Forced Expiratory Volume | Anticholinergics | Metaproterenol | Asthma (acute) | Cholinergic Antagonists | Adrenergic beta‐2 Receptor Agonists | Atropine | Bronchodilators | Levalbuterol | Beta‐agonists | Al